Jorge E. Cortes, MD, has been an investigative leader for nearly 30 years in the development of numerous leukemia treatments. It would be difficult to look at data involving practice-changing agents for patients with leukemia and miss the name Jorge E.
Creative Bioarray announced the release of its reliable and consistent FBS products for cell culture study. New York, USA December 24, 2021 Creative Bioarray, already established its cutting-edge platform majored in cell culture, focusing on offering biological and chemical products, and striving for solutions that can improve research outcomes and dramatically increase the speed of success
CLEVELAND- Newly designed chimeric antigen receptor (CAR) T-cells targeting the CD19 antigen are effective in treating adults and children with B-cell malignancies, especially when produced under place-of-care manufacturing which is available at University Hospitals (UH) Seidman Cancer Center. Thats the conclusion of a recent study published in the prestigious journal Nature Communications, detailing two Phase I clinical trials of CAR19 T-cells used to treat patients with relapsed/refractory pediatric B-cell Acute Lymphocytic Leukemia (ALL) or adult B-cell Lymphoma.
Something good always comes from something bad.
MELVILLE, N.Y., Dec. 20, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the Company" or BioRestorative) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today released the following year-end message.
PHILADELPHIA, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective as of market open on Monday, December 20, 2021. The NBI is designed to track the performance of a set of securities listed on the NASDAQ Stock Market® (NASDAQ®), made up of NASDAQ-listed companies classified as Biotechnology & Pharmaceuticals by the Industry Classification Benchmark (ICB), and is widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
One year ago this month, a $5.5 billion wave washed over Californias ambitious stem cell agency and left it refreshed and renewed for another decade or so of searching for miraculous treatments for a host of deadly, incurable afflictions. Officially known as the California Institute for Regenerative Medicine (CIRM), the agency has seized its new role with alacrity at least when it comes to awards. It is now on a pace to hand out $38,000 an hour, 24 hours a day, seven days a week
Significance The thyroid is essential for maintaining systemic homeostasis by regulating thyroid hormone concentrations in the bloodstream.
CAMBRIDGE, United Kingdom How did the human brain get so big? A recent study finds a key genetic switch is what separates people from their smaller-brained primate cousins.
With the rapid advancement of CAR T, there is no doubt that many patients in the future will reap the benefits. (CAR) T-cell therapy has revolutionized the treatment of hematologic malignancies since the initial approval of antiCD19 CAR T for acute lymphoblastic leukemia (ALL) in 2017.1 2021 proved an exceptionally busy year for approvals in CAR T therapeutics, with several ongoing trials showing that additional indications are not far behind. Brexucabtagene Autoleucel Brexucabtagene autoleucel (Tecartus, brexu-cel), a CD19-directed CAR T product, was approved on October 1, 2021, by the FDA for the treatment of adults with relapsed or refractory (R/R) B-cell precursor ALL (B-ALL)
Recent Comments